Prophylactic, Therapeutic, and Diagnostic Remedy for Treatment of Colibacillosis Infection
Green Technology! Veterinary: Avian DNA vaccine for colibacillosis (in chickens, turkeys, waterfowl) and potential diagnostics. Human: Potential human vaccine against urinary tract infections caused by E. coli.
Veterinary: Avian DNA vaccine for colibacillosis (in chickens, turkeys, waterfowl) and potential diagnostics. Human: Potential human vaccine against urinary tract infections caused by E. coli.
None
Patent Number: US6087128A
Application Number: US199823221A
Inventor: Nolan, Lisa K. | Horne, Shelley M.
Priority Date: 12 Feb 1998
Priority Number: US6087128A
Application Date: 12 Feb 1998
Publication Date: 11 Jul 2000
IPC Current: A61P003104 | C07K0014245 | C12N001531
US Class: 4350693 | 4350691 | 4353201 | 5360237
Assignee Applicant: NDSU Research Foundation,Fargo
Title: DNA encoding an avian E. coli iss
Usefulness: DNA encoding an avian E. coli iss
Summary: (I) is useful as vaccine for treating and preventing avian septicemic diseases and functions as a marker for diseases causing avian Escherichia coli.
Novelty: Nucleic acid molecule encoding Iss polypeptide isolated from avian Escherichia coli, used to prevent avian septicemic diseases and for diagnostic and control strategies for avian colibacillosis
生物醫學
DNA /基因工程
美國
